Avadel Pharmaceuticals, an Ireland-based biopharmaceutical company, disclosed a Form 13F filing with the SEC.
2 reports, 1 independent
Updated Sep 5
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Avadel Pharmaceuticals, an Ireland-based biopharmaceutical company, disclosed a Form 13F filing with the SEC.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Avadel Pharmaceuticals
specialty pharmaceutical company
Nothing else this week.
-
SEC
Slovak company
Related events
- First Financial Bank filed Form 13F disclosures with the Securities and Exchange Commission on June 26, 2026.
- Israel Discount Bank of New York filed a Form 13F with the SEC, boosting its holdings in ETF shares.
- Amazon.com, Inc. filed a Form 13F report with the Securities and Exchange Commission on October 18, 2026.
- Nvidia filed a Form 13F report with the SEC on October 24, 2026.
Coverage
Newest first; wire copies grouped- Insider MonkeyAvadel Pharmaceuticals (AVDL) Attracts Institutional Investment Avadel Pharmaceuticals plc (NASDAQ:AVDL) is among the fastest growing small cap stocks to buy. As disclosed in the latest Form 13F fili
- Insider MonkeyAvadel Pharmaceuticals plc (AVDL)’s LUMRYZ™ Sales Surge 64% in Breakout Quarter We recently compiled a list of the 11 Best Pharma Stocks to Invest in for the Long Term. Avadel Pharmaceuticals plc sta